admin February 7th, 2005
The Canadian Therapeutic Products Directorate have posted about the association of Ezetrol (ezetimibe) with myalgia, rhabdomyolysis, hepatitis, pancreatitis, and thrombocytopenia.
Merck Frosst/Schering Pharmaceuticals briefing for patients.
Merck Frosst/Schering Pharmaceuticals briefing for professionals.
admin December 22nd, 2004
Health Canada and Novartis have advised of reports of osteonecrosis of the jaw in cancer patients being treated with disodium pamidronate (Aredia) and zoledronic acid (Zometa).
Health Canada advisory
Dear Healthcare professional letter
admin December 19th, 2004
Two randomized, placebo-controlled clinical trials in patients immediately after coronary-artery bypass grafting showed that valdecoxib increased the risk of serious cardiovascular outcomes by a factor of approximately three.
Early release letter in New England Journal of Medicine (to be published 23/12/04)